Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1886 1
1945 1
1946 1
1947 2
1948 1
1949 1
1950 3
1951 2
1952 4
1953 3
1954 4
1955 3
1956 4
1957 4
1960 3
1961 2
1962 4
1964 1
1965 3
1967 1
1968 3
1969 3
1970 3
1971 3
1972 6
1973 3
1974 1
1975 3
1976 3
1978 1
1979 1
1982 1
1983 2
1985 2
1987 1
1988 5
1989 3
1990 4
1993 5
1994 3
1995 5
1996 1
1997 6
1998 6
1999 9
2000 5
2001 5
2002 5
2003 7
2004 8
2005 17
2006 14
2007 12
2008 30
2009 25
2010 34
2011 28
2012 35
2013 30
2014 33
2015 42
2016 36
2017 43
2018 39
2019 34
2020 50
2021 54
2022 35
2023 29
2024 31
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

711 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Among authors: o brien f. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Development of miR-26a-activated scaffold to promote healing of critical-sized bone defects through angiogenic and osteogenic mechanisms.
Sadowska JM, Ziminska M, Ferreira C, Matheson A, Balouch A, Bogle J, Wojda S, Redmond J, Elkashif A, Dunne N, McCarthy HO, Donahue S, O'Brien FJ. Sadowska JM, et al. Among authors: o brien fj. Biomaterials. 2023 Dec;303:122398. doi: 10.1016/j.biomaterials.2023.122398. Epub 2023 Nov 13. Biomaterials. 2023. PMID: 37979514 Free article.
Fluid homeostasis in the neonate.
O'Brien F, Walker IA. O'Brien F, et al. Paediatr Anaesth. 2014 Jan;24(1):49-59. doi: 10.1111/pan.12326. Epub 2013 Dec 4. Paediatr Anaesth. 2014. PMID: 24299660 Review.
Mechanomodulatory biomaterials prospects in scar prevention and treatment.
Fernandes MG, da Silva LP, Cerqueira MT, Ibañez R, Murphy CM, Reis RL, O Brien FJ, Marques AP. Fernandes MG, et al. Among authors: o brien fj. Acta Biomater. 2022 Sep 15;150:22-33. doi: 10.1016/j.actbio.2022.07.042. Epub 2022 Jul 29. Acta Biomater. 2022. PMID: 35914694 Free article. Review.
711 results